Results 161 to 170 of about 3,572,912 (194)

False Activations for ST-Segment Elevation Myocardial Infarction

Interventional Cardiology Clinics, 2016
First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem.
David C, Lange, Ivan C, Rokos, J Lee, Garvey, David M, Larson, Timothy D, Henry   +4 more
openaire   +2 more sources

Reperfusion Paradox in ST-Segment Elevation Myocardial Infarction

Annals of Internal Medicine, 2011
A transformation in ST-segment elevation myocardial infarction (STEMI) care in the United States has unfolded. It asserts superior reperfusion with primary percutaneous coronary intervention (PPCI) over fibrinolysis on the basis of studies showing the former method to be superior for reperfusion of patients with STEMI.
Paul W, Armstrong, William E, Boden
openaire   +2 more sources

Anticoagulation in the Management of ST-Segment Elevation Myocardial Infarction

Journal of Pharmacy Practice, 2010
Patients with ST-segment elevation myocardial infarction (STEMI) require immediate reperfusion therapy in order to salvage ischemic myocardial tissue and reduce mortality. Reperfusion therapy can be provided mechanically with primary percutaneous coronary intervention (PCI), or pharmacologically with fibrinolysis. Regardless of the reperfusion strategy
Paul P, Dobesh, Toby C, Trujillo
openaire   +2 more sources

Contemporary Management of ST-Segment Elevation Myocardial Infarction

Hospital Practice, 2012
Coronary heart disease is the leading cause of death worldwide. In the United States, approximately 1 of every 6 deaths in 2007 was caused by coronary heart disease. Clinical presentation in the acute setting is mostly due to atherosclerotic plaque rupture leading to flow limitation in the affected vessel, and myocardial ischemia and infarction.
Arun, Karunakaran, Wael, Sumaya, Julian P, Gunn, Allison C, Morton, Robert F, Storey   +4 more
openaire   +2 more sources

Bivalirudin in patients with ST-segment elevation myocardial infarction

The Lancet, 2022
J J, Coughlan, Adnan, Kastrati
openaire   +2 more sources

Is The Diagnosis ST-Segment Elevation or Non–ST-Segment Elevation Myocardial Infarction?

Circulation, 2018
Katsuhiko, Tsutsumi, Kengo, Tsukahara
openaire   +2 more sources

Biomarkers in the Diagnosis of ST-Segment Elevation Myocardial Infarction

JAMA Internal Medicine, 2016
no ...
openaire   +3 more sources

The Role of Platelets in ST-Segment Elevation Myocardial Infarction

The American Journal of Cardiology, 2006
Zenon, Huczek, Krzysztof J, Filipiak, Grzegorz, Opolski   +2 more
openaire   +2 more sources

ST-segment elevation myocardial infarction

2023
Abou Bakr M. Salama, Ahmad Gebreil, Ahmed Mohammed Shaker   +2 more
openaire   +1 more source

Transient ST-segment elevation myocardial infarction

American Heart Journal, 2008
openaire   +2 more sources